Search Results

Filter
  • 1-10 of  59 results for ""Cystadenocarcinoma, Serous""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes.

  • Authors : Robertson SE; Department of Gynecology Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.; Yasukawa M

Subjects: Epstein-Barr Virus Infections* ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/epidemiology ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/genetics

  • Source: PloS one [PLoS One] 2023 Dec 01; Vol. 18 (12), pp. e0294448. Date of Electronic Publication: 2023 Dec 01 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

PROM1, CXCL8, RUNX1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients.

  • Authors : Dansonka-Mieszkowska A; Laboratory of Genetic and Molecular Cancer Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Szafron LA

Subjects: Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/drug therapy ; Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/genetics ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/drug therapy

  • Source: PloS one [PLoS One] 2022 Jul 22; Vol. 17 (7), pp. e0271539. Date of Electronic Publication: 2022 Jul 22 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Single-cell analysis of a high-grade serous ovarian cancer cell line reveals transcriptomic changes and cell subpopulations sensitive to epigenetic combination treatment.

  • Authors : Sriramkumar S; Cell, Molecular and Cancer Biology Graduate Program and Medical Sciences Program, Indiana University School of Medicine, Bloomington, Indiana, United States of America.; Metcalfe TX

Subjects: Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/Cystadenocarcinoma, Serous*/genetics ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/drug therapy ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/genetics

  • Source: PloS one [PLoS One] 2022 Aug 03; Vol. 17 (8), pp. e0271584. Date of Electronic Publication: 2022 Aug 03 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes.

  • Authors : Saeed-Vafa D; Department of Anatomic Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America.; Marchion DC

Subjects: Caveolin 1/Caveolin 1/Caveolin 1/*metabolism ; Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/*metabolism ; Ovarian Neoplasms/Ovarian Neoplasms/Ovarian Neoplasms/*metabolism

  • Source: PloS one [PLoS One] 2021 Nov 23; Vol. 16 (11), pp. e0256615. Date of Electronic Publication: 2021 Nov 23 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

The blood transcriptome prior to ovarian cancer diagnosis: A case-control study in the NOWAC postgenome cohort.

  • Authors : Jareid M; Faculty of Health Sciences, Department of Community Medicine, UiT - The Arctic University of Norway, Tromsø, Norway.; Snapkov I

Subjects: Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/*blood ; Neoplasm Proteins/Neoplasm Proteins/Neoplasm Proteins/*genetics ; Ovarian Neoplasms/Ovarian Neoplasms/Ovarian Neoplasms/*blood

  • Source: PloS one [PLoS One] 2021 Aug 27; Vol. 16 (8), pp. e0256442. Date of Electronic Publication: 2021 Aug 27 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer.

  • Authors : Sopo M; Department of Gynecology, Kuopio University Hospital, Kuopio, Finland.; Sallinen H

Subjects: Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/*metabolism ; Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/*pathology ; Ovarian Neoplasms/Ovarian Neoplasms/Ovarian Neoplasms/*metabolism

  • Source: PloS one [PLoS One] 2020 Nov 05; Vol. 15 (11), pp. e0241484. Date of Electronic Publication: 2020 Nov 05 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene.

  • Authors : Mittempergher L; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Piskorz AM

Subjects: Mutation*; BRCA1 Protein/BRCA1 Protein/BRCA1 Protein/*genetics ; Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/*genetics

  • Source: PloS one [PLoS One] 2020 Jul 08; Vol. 15 (7), pp. e0235766. Date of Electronic Publication: 2020 Jul 08 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Notch3 signaling promotes tumor cell adhesion and progression in a murine epithelial ovarian cancer model.

  • Authors : Price JC; Integrated Program in Cellular Molecular and Biomedical Studies, Columbia University, New York, NY, United States of America.; Azizi E

Subjects: Carcinoma, Ovarian Epithelial/Carcinoma, Ovarian Epithelial/Carcinoma, Ovarian Epithelial/*secondary ; Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/*secondary ; Ovarian Neoplasms/Ovarian Neoplasms/Ovarian Neoplasms/*pathology

  • Source: PloS one [PLoS One] 2020 Jun 11; Vol. 15 (6), pp. e0233962. Date of Electronic Publication: 2020 Jun 11 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Dynamic contrast-enhanced perfusion parameters in ovarian cancer: Good accuracy in identifying high HIF-1α expression.

  • Authors : Lindgren A; University of Eastern Finland, Faculty of Health Sciences, School of Medicine, Institute of Clinical Medicine, Obstetrics and Gynecology, Kuopio, Finland.; Anttila M

Subjects: Contrast Media/Contrast Media/Contrast Media/*pharmacokinetics ; Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/*diagnostic imaging ; Gadolinium/Gadolinium/Gadolinium/*pharmacokinetics

  • Source: PloS one [PLoS One] 2019 Aug 22; Vol. 14 (8), pp. e0221340. Date of Electronic Publication: 2019 Aug 22 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients.

  • Authors : Gong W; Clinical Research Unit, Department of Obstetrics and Gynecology, Technical University of Munich, Munich, Germany.; Liu Y

Subjects: Up-Regulation*; Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/Cystadenocarcinoma, Serous/*pathology ; Kallikreins/Kallikreins/Kallikreins/*genetics

  • Source: PloS one [PLoS One] 2019 Feb 27; Vol. 14 (2), pp. e0212968. Date of Electronic Publication: 2019 Feb 27 (Print Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
  • 1-10 of  59 results for ""Cystadenocarcinoma, Serous""